Happiness Biotech Group (NASDAQ:HAPP) vs. Chromadex (NASDAQ:CDXC) Head-To-Head Survey

Happiness Biotech Group (NASDAQ:HAPP) and Chromadex (NASDAQ:CDXC) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings and dividends.

Valuation and Earnings

This table compares Happiness Biotech Group and Chromadex’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Happiness Biotech Group $63.94 million 1.83 $18.72 million N/A N/A
Chromadex $31.56 million 7.97 -$33.32 million ($0.61) -6.92

Happiness Biotech Group has higher revenue and earnings than Chromadex.

Profitability

This table compares Happiness Biotech Group and Chromadex’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Happiness Biotech Group N/A N/A N/A
Chromadex -74.55% -137.97% -72.62%

Analyst Ratings

This is a breakdown of current ratings for Happiness Biotech Group and Chromadex, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Happiness Biotech Group 0 0 1 0 3.00
Chromadex 0 0 3 0 3.00

Chromadex has a consensus price target of $6.33, indicating a potential upside of 50.08%. Given Chromadex’s higher probable upside, analysts clearly believe Chromadex is more favorable than Happiness Biotech Group.

Institutional & Insider Ownership

19.5% of Chromadex shares are owned by institutional investors. 10.3% of Chromadex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Happiness Biotech Group Company Profile

Happiness Biotech Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplements products made of Lucidum spore powder and others in the People's Republic of China. It also offers edible fungi. The company was founded in 2004 and is based in Nanping, the People's Republic of China.

Chromadex Company Profile

ChromaDex Corporation operates as a nutraceutical company. The company offers Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide (NAD) level used for healthy aging; and Immulina, a spirulina extract and compound, which is used for improving human immune function. It also provides reference standards and fine chemicals to conduct quality control of raw materials and finished products in dietary supplements, cosmetics, food and beverages, and pharmaceutical industries. In addition, the company offers a range of consulting services, including regulatory support, product development, risk management, and litigation support. The company markets and sells its products directly in the United States and Canada; and through international distributors. ChromaDex Corporation is based in Irvine, California.

Receive News & Ratings for Happiness Biotech Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Happiness Biotech Group and related companies with MarketBeat.com's FREE daily email newsletter.